Central pain modulation after subthalamic nucleus stimulation: A crossover randomized trial

Neurology

Volumn 81, Issue 7, 2013, Pages 633-640

  Marques, Ana ^a,d   Chassin, Olivier ^a   Morand, Dominique ^b   Pereira, Bruno ^b   Debilly, Bérengère ^a,d   Derost, Philippe ^a,d   Ulla, Miguel ^a,d   Lemaire, Jean Jacques ^c   Durif, Franck ^a,d  

^a Neurology Department   (France)

^b Délégation À la Recherche Clinique et À L'Innovation DRCI   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^d UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENSERAZIDE; BENSERAZIDE PLUS LEVODOPA; LEVODOPA; PLACEBO;

ACUTE DISEASE; ADULT; ARTICLE; BRAIN DEPTH STIMULATION; CENTRAL PAIN MODULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FOLLOW UP; HUMAN; MECHANICAL STIMULATION; NOCICEPTIVE PAIN; PAIN THRESHOLD; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBTHALAMIC NUCLEUS; THERMAL STIMULATION; UNIFIED PARKINSON DISEASE RATING SCALE;

ANTIPARKINSON AGENTS; CROSS-OVER STUDIES; DEEP BRAIN STIMULATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PAIN THRESHOLD; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS;

EID: 84884477879     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182a08d00     Document Type: Article

References (40)

1. Ford B. Pain in Parkinson's disease. Clin Neurosci 1998;5: 63-72.
2. Goetz CG. Pain in Parkinson's disease. Mov Disord 1986; 1:45-49.
3. Witjas T, Kaphan E, Azulay JP, et al. Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology 2002;59:408-413.
4. Ford B. Pain in Parkinson's disease. Mov Disord 2010;25 (suppl 1):S98-S103.
5. Snider SR, Fahn S, Isgreen WP, Cote LJ. Primary sensory symptoms in parkinsonism. Neurology 1976;26:423-429.
6. Koller WC. Sensory symptoms in Parkinson's disease. Neurology 1984;34:957-959.
7. Quinn NP, Koller WC, Lang AE, Marsden CD. Painful Parkinson's disease. Lancet 1986;1:1366-1369.
8. Ford B, Louis ED, Greene P, Fahn S. Oral and genital pain syndromes in Parkinson's disease. Mov Disord 1996; 11:421-426.
9. Sage JI, Kortis HI, Sommer W, Evidence for the role of spinal cord systems in Parkinson's disease-associated pain. Clin Neuropharmacol 1990;13:171-174.
10. Djaldetti R, Shifrin A, Rogowski Z, Sprecher E, Melamed E, Yarnitsky D. Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 2004;62: 2171-2175.
11. Kim HJ, Jeon BS, Paek SH. Chronic subthalamic deep brain stimulation improves pain in Parkinson disease. J Neurol 2008;255:1889-1894.
12. Gierthmuhlen J, Arning P, Binder A, et al. Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease. Mov Disord 2010;25:1195-1202.
13. Witjas T, Kaphan E, Régis J, et al. Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease. Mov Disord 2007;22:1729-1734.
14. Ciampi de Andrade D, Lefaucheur JP, Galhardoni R, et al. Subthalamic deep brain stimulation modulates small fiberdependant sensory thresholds in Parkinson's disease. Pain 2012;153:1107-1113.
15. Lemaire JJ, Durif F, Boire JY, Debilly B, Irthum B, Chazal J. Direct stereotactic MRI location in the globus pallidus for chronic stimulation in Parkinson's disease. Acta Neurochir 1999;141:759-765.
16. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
17. Brown GG, Rahill AA, Gorell JM, et al. Validity of the dementia rating scale in assessing cognitive function in Parkinson's disease. J Geriatr Psychiatry Neurol 1999;12: 180-188.
18. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382-389.
19. Lellouch J, Lazar P. Méthodes Statistiques en Expé rimentation Biologique. Paris: Flammarion Médecine Sciences; 1976.
20. Thobois S. Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature. Clin Ther 2006;28:1-12.
21. Fahn S, Elton RL; Members of the UPDRS Developmental Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, editors. Recent Developments in Parkinson's Disease. Vol. 2 Florham Park, NJ: Macmillan Healthcare Information; 1987: 153-163; 293-304.
22. Hindmarch I. Critical flicker fusion frequency (CFF): the effects of psychotropic compounds. Pharmacopsychiatry 1982;15:44-48.
23. Spielberger S, Wolf E, Kress M, Seppi K, Poewe W. The influence of deep brain stimulation on pain perception in Parkinson's disease. Mov Disord 2011;26:1367-1368.
24. Maruo T, Saitoh Y, Hosomi K, et al. Deep brain stimulation of the subthalamic nucleus improves temperature sensation in patients with Parkinson's disease. Pain 2011;152:860-865.
25. Dellapina E, Ory-Magne F, Regragui W, et al. Effect of subthalamic deep brain stimulation on pain in Parkinson's disease. Pain 2012;153:2267-2273.
26. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349: 1925-1934.
27. Benedetti F, Vighetti S, Ricco C, et al. Pain threshold and tolerance in Alzheimer's disease. Pain 1999;80:377-382.
28. Gibson SJ, Farrell M. A review of age differences in the neurophysiology of nociception and the perceptual experience of pain. Clin J Pain 2004;20:227-239.
29. Potvin S, Marchand S. Hypoalgesia in schizophrenia is independent of antipsychotic drugs: a systematic quantitative review of experimental studies. Pain 2008;138:70-78.
30. Mansikka H, Erbs E, Borrelli E, Pertovaara A. Influence of the dopamine D2 receptor knockout on pain-related behavior in the mouse. Brain Res 2005;1052:82-87.
31. Gear RW, Aley KO, Levine JD. Pain-induced analgesia mediated by mesolimbic reward circuits. J Neurosci 1999; 19:7175-7181.
32. Altier N, Stewart J. The role of dopamine in the nucleus accumbens in analgesia. Life Sci 1999;65:2269-2287.
33. Le Jeune F, Péron J, Grandjean D, et al. Subthalamic nucleus stimulation affects limbic and associative circuits: a PET study. Eur J Nucl Med Mol Imaging 2010;37: 1512-1520.
34. Marceglia S, Fumagalli M, Priori A. What neurophysiological recordings tell us about cognitive and behavioral functions of the human subthalamic nucleus. Expert Rev Neurother 2011;11:139-149.
35. Tinazzi M, Del Vesco C, Fincati E, et al. Pain and motor complications in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006;77:822-825.
36. Beiske AG, Loge JH, Rønningen A, Svensson E. Pain in Parkinson's disease: prevalence and characteristics. Pain 2009;141:173-177.
37. Gerdelat-Mas A, Simonetta-Moreau M, Thalamas C, et al. Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study. J Neurol Neurosurg Psychiatry 2007;78:1140-1142.
38. Brefel-Courbon C, Payoux P, Thalamas C, et al. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord 2005;20:1557-1563.
39. Magnusson JE, Fisher K. The involvement of dopamine in nociception: the role of D(1) and D(2) receptors in the dorsolateral striatum. Brain Res 2000;855: 260-266.
40. Cobacho N, De la Calle JL, González-Escalada JR, Paíno CL. Levodopa analgesia in experimental neuropathic pain. Brain Res Bull 2010;83:304-309.